Covered recipient · General Payments record
AMARA GAYATHRI NANDIKOLLA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,805.19
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $218.02 | 20 |
| Food and Beverage | $189.96 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $236.58 | 21 |
| Genmab U.S., Inc. | $70.28 | 1 |
| GENZYME CORPORATION | $26.56 | 1 |
| Acerta Pharma LLC | $24.29 | 1 |
| Myriad Genetic Laboratories, Inc. | $19.64 | 1 |
| Lilly USA, LLC | $15.62 | 1 |
| Stemline Therapeutics Inc. | $15.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $24.29 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104571338 | CMS |
| Genmab U.S., Inc. | $70.28 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126824088 | CMS |
| GENZYME CORPORATION | $26.56 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139775881 | CMS |
| Lilly USA, LLC | $15.62 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136029107 | CMS |
| Myriad Genetic Laboratories, Inc. | $19.64 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152536931 | CMS |
| PFIZER INC. | $11.88 | 02/19/2024 | Education | Undisputed | 01/23/2026 | 1131913701 | CMS |
| PFIZER INC. | $7.98 | 02/19/2024 | Education | Undisputed | 01/23/2026 | 1131922067 | CMS |
| PFIZER INC. | $11.88 | 02/23/2024 | Education | Undisputed | 01/23/2026 | 1131915834 | CMS |
| PFIZER INC. | $9.66 | 02/23/2024 | Education | Undisputed | 01/23/2026 | 1131921151 | CMS |
| PFIZER INC. | $16.01 | 03/05/2024 | Education | Undisputed | 01/23/2026 | 1131596341 | CMS |
| PFIZER INC. | $7.98 | 03/05/2024 | Education | Undisputed | 01/23/2026 | 1131910430 | CMS |
| PFIZER INC. | $16.01 | 03/21/2024 | Education | Undisputed | 01/23/2026 | 1131596345 | CMS |
| PFIZER INC. | $11.88 | 03/21/2024 | Education | Undisputed | 01/23/2026 | 1131906375 | CMS |
| PFIZER INC. | $11.88 | 05/01/2024 | Education | Undisputed | 01/23/2026 | 1131915476 | CMS |
| PFIZER INC. | $9.66 | 05/01/2024 | Education | Undisputed | 01/23/2026 | 1131923071 | CMS |
| PFIZER INC. | $11.88 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1131922655 | CMS |
| PFIZER INC. | $11.88 | 07/17/2024 | Education | Undisputed | 01/23/2026 | 1131947364 | CMS |
| PFIZER INC. | $7.98 | 10/15/2024 | Education | Undisputed | 01/23/2026 | 1131942445 | CMS |
| PFIZER INC. | $11.88 | 10/15/2024 | Education | Undisputed | 01/23/2026 | 1131983199 | CMS |
| PFIZER INC. | $7.98 | 10/31/2024 | Education | Undisputed | 01/23/2026 | 1131973513 | CMS |
| PFIZER INC. | $11.88 | 10/31/2024 | Education | Undisputed | 01/23/2026 | 1131991109 | CMS |
| PFIZER INC. | $11.88 | 11/01/2024 | Education | Undisputed | 01/23/2026 | 1131971885 | CMS |
| PFIZER INC. | $7.98 | 11/01/2024 | Education | Undisputed | 01/23/2026 | 1131978225 | CMS |
| PFIZER INC. | $18.56 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131128066 | CMS |
| PFIZER INC. | $11.88 | 11/25/2024 | Education | Undisputed | 01/23/2026 | 1131103874 | CMS |
| PFIZER INC. | $7.98 | 11/25/2024 | Education | Undisputed | 01/23/2026 | 1131170637 | CMS |
| Stemline Therapeutics Inc. | $15.01 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142957896 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.